Track market-moving stories before they get noisy

On July 13, TD Cowen analyst Joshua Buchalter maintained Microchip Technology at Hold and lowered the price target from $105 to $90.

When asked about Applied Optoelectronics (NASDAQ:AAOI), he said, “Not now. We need to wait until the speculative wave has passed.”

Applied Optoelectronics said it will report its second-quarter financial results on Thursday, Aug. 6.

According to recent news, Coca-Cola Consolidated declared a dividend of 25 cents per share on July 10 for the third quarter.

Cramer said he doesn’t know about ExlService Holdings, Inc. (NASDAQ:EXLS).

On July 9, TD Cowen analyst Bryan Bergin maintained ExlService at Buy and lowered the price target from $45 to $39.

Price Action:

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the materials sector.

Anglogold Ashanti PLC (NYSE:AU)International Paper Co (NYSE:IP)Amcor PLC (NYSE:AMCR)Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

When Berkshire Hathaway moves aggressively into three names in a single quarter, allocators pay attention. Greg Abel’s team, per the Q1 2026 13F, built or expanded positions in an airline, a mega-cap platform, and a homebuilder. Patient institutional capital is leaning into cyclicals and cash generators trading below what the underlying earnings power can support. Here is how the trio looks in July, with tool-verified data driving each thesis.

Delta Air Lines: A Cash Machine Absorbing a Fuel Shock Delta Air Lines (NYSE:DAL | DAL Price Prediction) is the boldest signal in the filing. Berkshire re-entering a legacy carrier is the kind of move that only makes sense if the underlying earnings trajectory has structurally changed. Delta’s numbers say it has.

Q2 2026 delivered adjusted EPS of $1.56 versus a $1.50 consensus, the fifth consecutive EPS beat. Delta produced $1.4 billion in pre-tax profit while absorbing the highest quarterly fuel expense in company history, $4.41 billion at $3.93 per gallon. Premium ticket revenue rose 17%, loyalty revenue jumped 19%, and American Express remuneration hit $2.40 billion, up 16%. Diversified, high-margin revenue streams now account for 61% of the total, which is why Delta absorbed a 77% year-over-year fuel expense increase and still guided FY2026 EPS to $6.50 to $7.50 with roughly 20% earnings growth. Management also announced a 15% dividend increase beginning the September quarter.

Shares traded around $86.19 on July 16, up more than 55% over the past year. The Street is aligned: 96% bullish, with 25 Buy or Strong Buy ratings against a single Sell rating, and an analyst target of $99.56. That is roughly 14x trailing earnings for a business generating record free cash flow at scale.

Risk: Operating margin compressed 4.5 points to 8.8%, and non-fuel unit costs rose 6.8% YoY, above the long-term target. If fuel stays elevated into 2027, the 20% earnings growth story slips.

Alphabet: Cloud Backlog Doubled, Yet the Stock Trades Like Value Alphabet (NASDAQ:GOOGL) is the AI infrastructure trade Berkshire evidently wants to own. Q1 2026 was a blowout: EPS of $5.11 versus a $2.63 estimate, revenue of $109.90 billion (+21.8% YoY). Google Cloud posted $20.03 billion in revenue, up 63%, and Sundar Pichai flagged that “Google Cloud revenues grew 63% with backlog nearly doubling quarter on quarter to over $460 billion.”

Search remains the cash engine: $60.40 billion in revenue, up 19%. Paid subscriptions crossed 350 million, Gemini processes 16 billion tokens per minute, and Waymo now runs more than 500,000 fully autonomous rides per week. Operating income expanded 30% to $39.70 billion, with an operating margin of 36.1%.

On July 16, shares traded around $373.61, up more than 104% over the trailing year yet still below the 52-week high of $408.37. Analysts sit at $431.91, with 57 Buy or Strong Buy ratings, seven Hold ratings and zero Sell ratings. At a forward P/E near 25 for a business compounding earnings at 82% year over year, the setup is asymmetric.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Google didn't make the cut. Grab the names FREE today.

Risk: FY2026 CapEx guidance of $175 to $185 billion is straining free cash flow, which fell 46.6% YoY in Q1. If AI monetization lags the buildout, that gap widens before it closes.

Lennar: The Contrarian Housing Bet Lennar (NYSE:LEN) is the deep-value leg. Shares are down more than 17% year to date and more than 20% over the past year, trading at roughly 0.94x book value. Berkshire buying here is a bet that the mortgage-rate freeze on affordability is thawing.

Q2 fiscal 2026 delivered EPS of $1.24 on revenue of $7.94 billion, with gross margin on home sales of 15.6%, up sequentially from the Q1 trough. CEO Stuart Miller framed the margin catalyst directly: “The gap between our current incentive levels of 12.9% and normalized levels of 4% to 6% is narrowing for the first time in three years as the mismatch between higher home prices with higher interest rates and household income is narrowing.” That is the margin recovery catalyst, and base-case modeling puts the stock at $95.50 within a year, a 15.28% return, with a bull case at $113.51.

Operationally, Lennar is running the leanest homebuilder in the market: construction cycle time of 121 days, down from 132, construction costs down 13% over several years, and less than 5% of land on the balance sheet. The company bought back 5 million shares at an average $89.35 for $447 million in Q2. Miller added: “Demand is real, deferred, and building. Lennar is positioned better than at any point in recent history to capture demand as conditions normalize.”

Risk: Analyst sentiment is genuinely mixed: only 11% bullish, 44% bearish, with five Strong Sell ratings. Miller cited “a resurgent inflation reading of 4.2% driven by higher energy prices,” and if rates stay pinned, the incentive-normalization thesis stalls.

What to Watch Next The through-line: three cyclicals with self-help stories, buying back stock, and generating cash before their end markets fully re-rate. Watch Delta’s Q3 EPS against the $2.00 to $2.50 guide, Alphabet’s next capex commentary, and Lennar’s Q3 gross margin against the ~16% target. If each hits, Berkshire’s Q1 build will look early rather than lucky.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Google didn't make the cut. Grab the names FREE today.

Contact [email protected] for any questions or corrections.

Fifth Third Bancorp (FITB - Free Report) came out with quarterly earnings of $1.02 per share, beating the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $0.9 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +4.08%. A quarter ago, it was expected that this company would post earnings of $0.84 per share when it actually produced earnings of $0.83, delivering a surprise of -1.19%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Fifth Third Bancorp, which belongs to the Zacks Banks - Major Regional industry, posted revenues of $3.28 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 0.88%. This compares to year-ago revenues of $2.25 billion. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Fifth Third Bancorp shares have added about 26.8% since the beginning of the year versus the S&P 500's gain of 10.1%.

What's Next for Fifth Third Bancorp?While Fifth Third Bancorp has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Fifth Third Bancorp was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.09 on $3.34 billion in revenues for the coming quarter and $4.12 on $12.82 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Banks - Major Regional is currently in the top 10% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, Northern Trust Corporation (NTRS - Free Report) , is yet to report results for the quarter ended June 2026. The results are expected to be released on July 22.

This company is expected to post quarterly earnings of $2.68 per share in its upcoming report, which represents a year-over-year change of +25.8%. The consensus EPS estimate for the quarter has been revised 3.5% higher over the last 30 days to the current level.

Northern Trust Corporation's revenues are expected to be $2.2 billion, up 10.1% from the year-ago quarter.

Fifth Third Bancorp reported a rise in second-quarter profit on Friday, helped by higher net ​interest income and fee growth in capital markets ‌and wealth management businesses.

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Peabody Energy Corporation (NYSE:BTU) and certain of the Company’s senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws.

If you invested in Peabody, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/peabody-class-action-lawsuit.

Key Details of the Peabody ($BTU) Class Action:

Lead Plaintiff Deadline: August 24, 2026Alleged Misconduct: Securities fraud relating to Peabody’s statements about the coal production at Centurion, its flagship premium hard coking coal mine.Largest Alleged Stock Drop: March 30, 2026 – 9.7% stock dropCourt: U.S. District Court for the Eastern District of MissouriAction: Contact BFA Law to discuss your rights Investors have until August 24, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Peabody common stock. The class action is pending in the U.S. District Court for the Eastern District of Missouri. It is captioned McGeachy v. Peabody, et al., No. 26-cv-01020.

Why is Peabody Being Sued for Securities Fraud?

Peabody is a producer of metallurgic and thermal coal that owns interests in 16 active coal mining operations in the United States and Australia.

According to the complaint, during the relevant period, Peabody announced it would be increasing production from its flagship premium hard coking coal mine, Centurion due to an acceleration of longwall operations. Peabody stated that shipments of Centurion’s premium hard coking coal would expand sevenfold in 2026 to 3.5 million tons and even more beyond that time. On February 5, 2026, Peabody indicated that the team was “putting the finishing touches on the Centurion mine in advance of starting longwall mining, well ahead of its original schedule.”

As alleged, in truth, the Centurion mine was facing significant commissioning challenges resulting in increased costs and volume decreases in its production.

Why did Peabody’s Stock Drop?

On March 30, 2026, Peabody announced lower sales volume from the Centurion mine due to a delivery of only 250,000 tons in the first quarter. Peabody attributed the low volume to “greater than anticipated mine commissioning challenges.”

This news caused the price of Peabody common stock to drop $3.82 per share, or 9.7%, from $39.50 per share on March 27, 2026, to $35.68 per share on March 30, 2026.

Then, on May 5, 2026, Peabody announced additional delays to the commissioning of the Centurion mine as well as increased costs and lower volume. Peabody stated it only expected to sell about 300,000 tons in the second quarter and reduced its full year sales outlook for Centurion from 3.5 million tons to 2.5 million tons.

This news caused the price of Peabody common stock to drop $1.52 per share, or 5.7%, from $26.52 per share on May 4, 2026, to $25.00 per share on May 5, 2025.

Click here for more information: https://www.bfalaw.com/cases/peabody-class-action-lawsuit.

What Can You Do?

If you invested in Peabody, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/peabody-class-action-lawsuit

Or contact:

Adam McCall
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.

Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”

Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/peabody-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

Truist Financial logo appears in this illustration taken December 1, 2025. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab

July 17 (Reuters) - Truist Financial (TFC.N), opens new tab reported a higher quarterly profit on Friday, as ​a rebound in capital markets activity helped boost earnings ‌from investment banking, while volatility fueled trading desks.

Across the industry, banks have reaped gains from a revival in dealmaking that ​has bolstered lucrative advisory fees, while heightened ​market volatility has fueled client activity across ⁠their trading desks.

Get a look at the day ahead in U.S. and global markets with the Morning Bid U.S. newsletter. Sign up here.

Here are some details:

Truist's investment banking ​and trading income climbed nearly 72% in the three ​months ended June 30 from a year earlier.

Shares of the bank rose 1.9% in premarket trading.

Banks expect more gains ahead, with ​executives pointing to healthy pipelines and strong backlogs ​for the second half, fueling expectations that the investment banking "super ‌cycle" ⁠has more room to run.

Meanwhile, global markets remain volatile as the interest rate trajectory remains uncertain, geopolitical tensions linger and AI-driven tech jitters persist — an environment ​that typically keeps ​trading desks ⁠humming.

"We continued to deepen client relationships, grow in attractive markets, and improve operating ​efficiency and profitability," Truist CEO Bill ​Rogers ⁠said.

The bank's wealth management income for the second quarter also increased 7.8%.

Truist's quarterly net income available to common ⁠shareholders ​came in at $1.52 billion or $1.23 ​per share, above last year's $1.18 billion or 90 cents per share.

Reporting ​by Manya Saini in Bengaluru; Editing by Diti Pujara

Our Standards: The Thomson Reuters Trust Principles., opens new tab

It's fair to say that ON Semiconductor's (ON 4.82%) $7 billion acquisition of artificial intelligence (AI) edge solutions company Synaptics (SYNA 4.97%) didn't receive a warm welcome from the market. The stock sold off sharply on the announcement and has only recovered slightly since. It's a bold move that needs some explaining, not least because the sell-off could be a great opportunity for investors. Here's why.

ON Semiconductor in 2026 The slump in the share price likely occurred because investors woke up to a fundamentally different company after the deal was announced. The company is best known for its power and sensing chips sold to its key automotive (electric vehicles) and industrial verticals. It also has fast-growing revenue from AI data centers, and its partnership with Nvidia to create power chips for a new generation of data centers promises to accelerate its growth.

Today's Change

(

-4.82

%) $

-4.46

Current Price

$

88.08

In fact, I selected the company as my top stock to buy for 2026 on the basis of a cyclical recovery in its EV and industrial end markets, combined with its AI data center revenue and a highly compelling cash-flow-based valuation.

The company didn't disappoint, nor did its end markets, but with one bound, investors are suddenly faced with a new investment proposition, and it's causing some consternation.

ON Semiconductor's big move The definitive agreement to buy Synaptics suddenly transforms ON Semiconductor from a company with power and sensing technology into one that can also offer connected compute technology. For some real-world examples, consider an industrial robot that needs power and sensors (from ON Semiconductor) to function, but also requires connected computing power (from Synaptics) to operate.

In this sense, the new company will be able to capture more value from physical AI. This is why ON Semiconductor's management describes the deal as an expansion of its capability from AI infrastructure to physical AI. It also believes that acquiring Synaptics will expand its total addressable market (TAM) "by $30 billion to $243 billion by 2030."

Image source: Getty Images.

Numbers backing the deal Management expect the all-stock transaction to add to earnings per share within 18 months of the close. The following estimates were given in the deal presentation.

One key point to note is that buying Synaptics increases profit and gross profit margin. However, Synaptics has lower operating profit margins. That said, management believes it can generate $200 million in synergies (in about 18 months after the deal closes) from the deal, with "probably 85% to 90%" from operating expenses and the rest from cost of goods sold.

In other words, operating profit margin will get a boost from the deal's synergies.

Wall Street Consensus

ON Semiconductor

Synaptics

New Company

Revenue

$6.5 billion

$1.3 billion

$7.8 billion

Gross profit

$2.6 billion

$0.7 billion

$3.3 billion

Margin

40%

54%

42%

Operating profit

$1.4 billion

$0.2 billion

$1.7 billion*

Margin

22%

19%

22%

Data source: ON Semiconductor. *Discrepancy due to rounding.

Is ON Semiconductor stock a buy? There's an obvious concern that the acquisition will represent a leap from the power and sensing technology the company was focused on expanding to edge AI processing, which might not prove easy to execute. In addition, investing in edge AI is not why many holders invested in the stock in the first place.

Although those concerns are understandable, it's worth noting that many investors are focusing on AI infrastructure for model training right now. However, the future of AI is likely to be dominated by inference (running models) at the edge, which is why ON Semiconductor is buying Synaptics.

Image source: Getty Images.

The company already has strong exposure to the theme (robots and autonomous machines need power and sensing technology), and with the addition of the connected computing "brain" from Synaptics, the value added for ON Semiconductor from inference spending will only increase.

All told, it's an early and bold move into the long-term growth market of AI, and that will attract many investors willing to give management the benefit of the doubt over the move. As such, the dip in the share price looks like a decent buying opportunity.

HomeMarketsTed Oakley says investors are passing up commodity-stock opportunitiesJuly 17, 2026, 7:46 a.m. ET

Agnico Eagle Mines’ underground hauling trucks in an undated photo. Oxbow Advisors says investors are overlooking mining companies like Agnico. Photo: Photo courtesy of Agnico Eagle Mines LimitedA “generational bear market” is looming for investors with little powder to take advantage of, as they have chased rising popular stocks, warns one veteran wealth manager.

“In something like that, you’ll probably correct at least 40%, if not more,” Ted Oakley, the founder and managing partner of Oxbow Advisors, told The Julia La Roche show in an episode that aired Thursday.

ManpowerGroup Inc. (NYSE:MAN) on Thursday reported upbeat second-quarter results and issued third-quarter earnings guidance above expectations.

Adjusted earnings were 99 cents per share, topping analysts’ consensus estimate of 95 cents. Revenue rose 8% year over year to $4.86 billion, or 6% in constant currency, exceeding estimates of $4.72 billion.

For the third quarter, ManpowerGroup forecast diluted earnings of 96 cents to $1.06 per share, including an estimated 2-cent unfavorable currency impact. The guidance compares with analysts’ consensus estimate of 88 cents per share. The company expects approximately 6% organic, days-adjusted constant-currency revenue growth and an effective tax rate of about 44%.

ManpowerGroup shares jumped 32.4% to close at $51.65 on Thursday.

These analysts made changes to their price targets on ManpowerGroup following earnings announcement.

Baird analyst Mark Marcon maintained the stock with an Outperform rating and raised the price target from $45 to $72. UBS analyst Joshua Chan maintained the stock with a Neutral and raised the price target from $41 to $55. Considering buying MAN stock? Here’s what analysts think:

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

17.7.2026 14:33

Index importních cen (m-m) (červen):
aktuální hodnota: 0,3 %
očekávání trhu: -0,7 %
předchozí hodnota: 1,9 % / revize: 1,7 %

Index importních cen (y-y) (červen):
aktuální hodnota: 7,1 %
očekávání trhu: 6,5 %
předchozí hodnota: 6,7 % / revize: 6,6 %

Index exportních cen (y-y) (červen):
aktuální hodnota: 10,2 %
očekávání trhu: 10,2 %
předchozí hodnota: 11,2 % / revize: 11,3 %

Zdroj: Bloomberg

Michal Šnobl
Fio banka, a.s.
Prohlášení

Americké futures kontrakty klesají, Nasdaq 100 futures -1,92 %

HomeDividends AnalysisDividend IdeasConsumer Staples Analysis

SummaryConagra Brands, Inc. reported Q4 '26 earnings earlier today. Net organic sales were flat following a 1.6% decline in volume entirely offset by a 1.6% increase in price/mix.Based on the newly released guidance for fiscal 2027, net organic sales are expected to decline between 1% and 3%, and adjusted operating margins are expected to contract further to around 10%.This would mark the fourth consecutive year of organic net sales declines and margin compression. To provide some context, the company's operating margins were in excess of 15% in 2023.Conagra currently trades at ~8.4x the forward earnings expected in fiscal 2028. With this kind of valuation multiple, a significant amount of bad news is already incorporated in the price.With the 50% dividend cut announced today, CAG will now be focused on strengthening its balance sheet by bringing its net leverage ratio closer to the target of 3.0x adjusted EBITDA. This is compared to the 3.8x EBITDA reported at the end of Q4-26. JHVEPhoto/iStock Editorial via Getty Images

A Step In The Right Direction I published my first article on Conagra Brands, Inc. (CAG) back in April 2026. My Buy rating was primarily based on the fact that the company's

3.3K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of CAG, TAP either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Planet Fitness, Inc. (NYSE:PLNT) for potential securities fraud after its significant stock drop.

If you invested in Planet Fitness, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/planet-fitness-class-action-lawsuit.

Key Details of the Planet Fitness ($PLNT) Class Action Investigation:

Investigation Overview: Securities fraud regarding Planet Fitness’s failed marketing campaign that alienated the company’s core market and led to disappointing membership growth during the key Q1 sign-up period.Stock Decline: May 7, 2026 – 31% Stock DropAction: Contact BFA Law to discuss your rights Why is Planet Fitness Being Investigated for Securities Fraud?

Planet Fitness is a large franchisor and operator of fitness centers across the United States. The company aims to offer a fitness experience in a non-intimidating environment, which it calls the Judgement Free Zone. 

BFA is investigating whether Planet Fitness made false and misleading statements to investors regarding the purported success of its marketing campaign to focus on “fitness-minded” members.

Why did Planet Fitness’s Stock Drop?

On May 7, 2026, Planet Fitness released its Q1 2026 financial results. The company announced disappointing membership growth and cut 2026 revenue growth guidance from approximately 9% to about 7% and adjusted EBITDA growth guidance from roughly 10% to approximately 6%. During the same-day earnings call, the company stated that its marketing “may have pivoted too far” as the company “shift[ed] from [its] lighthearted approachable tone” to one that “increased penetration with the fitness-minded.”

This news caused the price of Planet Fitness stock to decline $19.95 per share, or 31%, from a closing price of $63.96 per share on May 6, 2026, to $44.01 per share on May 7, 2026.

Click here for more information: https://www.bfalaw.com/cases/planet-fitness-class-action-lawsuit.

What Can You Do?

If you invested in Planet Fitness, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/planet-fitness-class-action-lawsuit

Or contact:

Adam McCall
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.

Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.” 

Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/planet-fitness-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

Archer Aviation (ACHR 6.38%) recently slipped below $5, extending a decline that has surprised many investors. Yet the sell-off doesn't appear to reflect a sudden deterioration in the company's business.

Instead, it reflects something more subtle. The market is changing how it evaluates Archer.

A year ago, investors mainly cared about the company's vision. Flying taxis promised to transform urban transportation. Archer had secured partnerships with companies such as Stellantis and United Airlines, and each certification milestone reinforced the belief that commercialization was approaching.

Today, that narrative isn't enough. Investors are no longer asking whether flying taxis could become a major industry. They're asking a much tougher question: Can Archer build a profitable business before it runs out of time -- or capital?

Image source: Getty Images.

Commercialization has become the biggest test For years, Archer measured success through milestones:

Prototype flights Manufacturing progress Strategic partnerships Regulatory approvals Each announcement reduced uncertainty and helped investors believe the company was moving in the right direction. But as Archer approaches its goal of launching commercial operations in 2026, those milestones no longer carry the same weight. Investors now want evidence that the business itself is nearing takeoff.

Launching an air taxi service involves far more than building an aircraft. Archer must complete Federal Aviation Administration certification, prepare pilots, establish operating procedures, deploy supporting infrastructure, and convince customers to choose flying taxis over existing forms of transport.

Even then, another challenge begins. Can the business generate enough demand to operate profitably? Can aircraft fly frequently enough to justify their cost? Can the company eventually earn attractive returns after maintenance, staffing, insurance, and infrastructure expenses?

These are the questions investors are beginning to ask, and none has a satisfactory answer today. That's why each quarter without meaningful commercial revenue matters more than the one before it. The closer Archer gets to commercialization, the less investors value promises and the more they expect measurable progress.

Today's Change

(

-6.38

%) $

-0.31

Current Price

$

4.48

Cash burn isn't the biggest concern anymore. Dilution is. Ironically, Archer's biggest financial strength has created a new investor concern.

During the past two years, the company has raised substantial capital and built one of the strongest balance sheets in the electrical vertical takeoff and landing (eVTOL) industry. That gives management valuable time to complete certification and prepare for launch. For perspective, the company ended March 31 with $1.8 billion in liquidity.

Few investors now question whether Archer can survive.

Instead, they question how much of the company today's shareholders will still own by the time it succeeds.

Archer continues to invest heavily in engineering, certification, manufacturing capacity, and commercial preparation. Those investments are necessary, but they also mean the company is likely to remain cash-flow-negative for several more years. In 2025 alone, the company consumed $433 million in operating cash flow.

If commercialization takes longer than expected -- or scaling proves more expensive than planned -- raising additional capital may become necessary. That's where dilution becomes a real risk.

Every new share issued helps fund the business, but it also reduces the ownership stake of existing shareholders. Even if Archer ultimately succeeds, repeated equity issuance could reduce the returns investors earn.

For a company that remains years away from profitability, that's an important risk to consider.

What does it mean for investors? Nothing in Archer's recent progress suggests the long-term vision has fallen apart. The company continues to progress through certification, expand manufacturing capabilities, and prepare for a commercial launch in the U.S. in 2026. Those remain meaningful achievements.

What has changed is the market's willingness to pay for future potential. Investors now want evidence that Archer can convert technological progress into commercial success -- and eventually into sustainable profits.

That means another partnership announcement or another successful test flight won't define the next chapter. It will be defined by execution.

Can Archer launch commercial operations on schedule? Can it generate meaningful revenue? Can it reach that point without excessive shareholder dilution?

Those are the questions that will likely determine where the stock goes next.

The Euro (EUR) records mild losses against the US Dollar (USD) for the second consecutive day on Friday. The EUR/USD pair trades at 1,1430 after being capped at 1.1480 earlier this week, extending the sideways trend, as geopolitical tensions and higher oil prices keep Euro rallies subdued.

Hostilities in Iran escalated this week, with the US military killing eight people after attacking civilian targets in Bandar Abbas on Friday, while Tehran threatened to close the Bab el-Mandeb strait, another key corridor for gas and oil traffic.

The deteriorating situation in the Middle East has pushed oil prices higher this week. The barrel of Brent Crude is set to close the week near $85.00, about 18% above early June lows. This has offset the positive impact on the Euro of the soft US inflation data and lowered hopes of Federal Reserve (Fed) tightening.

Technical Analysis: The pair keeps looking for direction around 1.1400

The technical picture is little changed this week. EUR/USD keeps trading within a roughly 100-pip range, with momentum indicators on intraday charts showing a lack of clear bias. The 4-hour Relative Strength Index (14) is wavering near the 50 midline, and the Moving Average Convergence Divergence (MACD) slips fractionally negative, together hinting at subdued momentum.

On the topside, initial resistance emerges in the area between the mentioned range top, near 1.1480, and a previous support at the 1.1500 area (June 8 and 11 lows). A break above these levels would encourage bulls to target the June 16 and 17 highs, near 1.1620.

On the downside, immediate support is seen at the July range floor, between 1.1360 and 1.1380, which, so far, is closing the path towards the year-to-date low, at 1.1324. Further down, bears might be attracted by the late-May 2025 low, at 1.1210.

(The technical analysis of this story was written with the help of an AI tool. Know more.)

Euro Price This week The table below shows the percentage change of Euro (EUR) against listed major currencies this week. Euro was the strongest against the Japanese Yen.

USDEURGBPJPYCADAUDNZDCHFUSD-0.26%-0.39%0.34%-0.95%-0.44%-1.24%-0.10%EUR0.26%-0.13%0.63%-0.70%-0.23%-0.98%0.17%GBP0.39%0.13%0.72%-0.56%-0.09%-0.85%0.35%JPY-0.34%-0.63%-0.72%-1.37%-0.79%-1.62%-0.49%CAD0.95%0.70%0.56%1.37%0.59%-0.25%0.92%AUD0.44%0.23%0.09%0.79%-0.59%-0.75%0.31%NZD1.24%0.98%0.85%1.62%0.25%0.75%1.21%CHF0.10%-0.17%-0.35%0.49%-0.92%-0.31%-1.21% The heat map shows percentage changes of major currencies against each other. The base currency is picked from the left column, while the quote currency is picked from the top row. For example, if you pick the Euro from the left column and move along the horizontal line to the US Dollar, the percentage change displayed in the box will represent EUR (base)/USD (quote).

Greatland Resources Ltd (AIM:GGP, OTC:GRLGF, FRA:G8G, ASX:GGP) will release its Quarterly Activities Report for the June 2026 quarter on Wednesday, July 29, 2026.

The company will host a webcast for shareholders, research analysts, media and other interested stakeholders at 8:30am AWST / 10:30am AEST on the same day, followed by a question-and-answer session.

Participants can register for the June 2026 quarter webcast using the link below:

https://webcast.openbriefing.com/ggp-qtr4-2026/

Attendees are encouraged to log in at least five minutes before the scheduled start time to complete registration. A recording of the presentation will be available through the same link following the webcast.

Greatland Resources beats FY26 gold guidance and lifts cash to US$1.29 billion Greatland will no doubt cover how it exceeded the top end of its full-year gold production guidance after a strong June quarter, while building its cash balance to almost US$1.3 billion with no debt.

The miner produced 79,099 ounces of gold and 3,573 tonnes of copper in the three months to June 30, 2026, taking FY26 output to 328,986 ounces of gold and 14,594 tonnes of copper.

Full-year gold production finished 6% above the upper end of Greatland’s guidance range.

Quarterly sales totalled 74,648 ounces of gold and 3,531 tonnes of copper, bringing full-year sales to 326,859 ounces of gold and 14,729 tonnes of copper.

Greatland ended June with US$1.29 billion in cash, up from US$1.21 billion at the end of March. The US$81 million quarterly cash build came after capital expenditure and US$87 million in tax instalments.

A further US$20 million of sales were completed in late June, with the proceeds received after quarter-end.

The company said all-in sustaining cost figures were still being finalised and would be included in its full June 2026 quarterly activities report later this month.

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) earlier this week strengthened its intellectual property position in Southeast Asia after securing a Vietnamese patent covering the manufacture and use of its RECCE® 327 and RECCE® 529 synthetic anti-infective candidates.

The Family 4 patent, granted by the Intellectual Property Office of Vietnam, provides protection until 2041 and represents the eighth patent secured by the company within this patent family.

Chief executive James Graham said the award was significant because it extended Recce Pharmaceuticals’ potential market monopoly in Vietnam to 2041. He explained that the claims covered the preparation and manufacture of R327 and R529, as well as their use against bacterial, viral and other infectious diseases.

Graham described the patent as “broad” and “all-encompassing”, with potential applications including acute bacterial skin and skin structure infections, diabetic foot ulcer infections and burn wound infections.

Vietnam was strategically important because it formed part of the ASEAN group of countries, Graham said. He pointed to the prevalence of diabetes in the region and the associated risk of infected diabetic foot ulcers, while also highlighting high levels of resistance to existing antibiotics and the absence of an established standard of care in some markets.

The company’s Indonesian Phase 3 program represented one of the most important near-term catalysts. Graham said Recce Pharmaceuticals remained on track for potential approval in Indonesia later in the year, with sales targeted for the following year. He added that an Indonesian approval could support broader access across ASEAN, including Vietnam.

A second Phase 3 study was being conducted across Australian teaching hospitals. Graham said this program was being run to US Food and Drug Administration standards and under an FDA-aligned protocol, with a submission targeted for the end of the following year.

Licensing activity provided another potential catalyst. Recce Pharmaceuticals had announced a term sheet with a leading Middle Eastern pharmaceutical company covering approximately 11 countries and a proposed 10-year licence.

Graham said the arrangement was targeting net royalties of between 30% and 36%, based on a US$1,500 selling price. He said the company was actively working to convert the term sheet into a definitive agreement.

The company’s recently raised funds were expected to support its clinical, regulatory and licensing activities. Investors are likely to focus on upcoming Phase 3 data, the anticipated Indonesian regulatory decision, progress on the Middle Eastern licence and further expansion of Recce Pharmaceuticals’ global patent portfolio.

Interview highlights Recce Pharmaceuticals secured a Vietnamese Family 4 patent covering the manufacture and use of RECCE® 327 and RECCE® 529. The patent extends protection in Vietnam until 2041 and is the eighth granted patent within the Family 4 portfolio. The claims cover bacterial, viral and other infectious diseases, including acute bacterial skin infections, diabetic foot ulcer infections and burn wound infections. James Graham identified Vietnam as strategically important because it is part of ASEAN and has a significant diabetes-related disease burden. The company is progressing two Phase 3 studies focused on diabetic foot ulcer infections, including programs in Indonesia and Australia. Recce Pharmaceuticals expects the Indonesian program to support an anticipated approval pathway and future sales across ASEAN markets. The Australian study is being conducted across teaching hospitals to standards intended to support a future US FDA submission. The company is also progressing a Middle Eastern licensing opportunity covering about 11 countries under a proposed 10-year agreement. Graham said the proposed licence could deliver net royalties of between 30% and 36%, based on a US$1,500 selling price. Near-term catalysts include Phase 3 clinical data, potential Indonesian approval, progress towards a definitive Middle Eastern licensing agreement and further regulatory activity.

Proactive: Recce Pharmaceuticals has strengthened its intellectual property position in Southeast Asia after securing a Vietnamese patent covering its RECCE® 327 and RECCE® 529 anti-infective candidates. Here to discuss the patent and the Vietnamese market is CEO James Graham. James, good to see you again.

James Graham: Hi, Jonathan. Good to be with you.

Proactive: Let’s talk about the Vietnamese patent first. Talk us through how it came about and why this protection is important for the candidates.

James Graham: It is very significant because it takes our market monopolies out to 2041. Furthermore, the patent claims on which these monopolies are based cover the preparation, or method of manufacture, of our compounds.

That includes RECCE 327 for bacterial infections and RECCE 529 for viral infections. It covers topical infections, including acute bacterial skin and skin structure infections, diabetic foot ulcer infections, where we have two Phase 3 programs at the moment, potential first standard-of-care treatment for burn wound infections, and beyond.

It is a broad, all-encompassing patent and is wholly owned intellectual property.

Proactive: Talk us through Vietnam. Why is it a strategically important market for Recce Pharmaceuticals?

James Graham: Vietnam, as a member of the ASEAN group of countries, is a very important market for us.

Firstly, the prevalence of diabetes runs at about 12% in that region. Of those who have diabetes, around 60% will develop a diabetic foot ulcer in their lifetime, and about 80% of those ulcers become infected.

Penicillin, by way of example, was invented in Australia nearly 100 years ago. Next year will mark its centenary. It has a resistance rate of about 75%, so the resistance profile is enormous.

Furthermore, there is no standard of care in the region. We have a Phase 3 study currently running in Indonesia. If approved in Indonesia, as we are on track to achieve later this year, with sales targeted for next year, that approval would support access across the ASEAN group of countries, including Vietnam.

We therefore have a strong intellectual property position, the potential for a first standard of care and the first new antibiotic in more than 40 years.

Proactive: You have been building that patent protection over the past couple of years, and we have discussed several of those patents. How does this latest approval strengthen the broader global patent portfolio and support future commercialisation opportunities?

James Graham: We have five patent families, perhaps even six depending on our recent patent application.

In this case, it is our Family 4 patent. We have had eight patents granted in that family over the recent year or small number of years.

This particular family is broad, covering the method of manufacture, preventative claims, curative claims, viral infections and bacterial infections.

It takes our market monopolies out to 2041, providing a strong market monopoly and an extended timeframe. It is also complementary to the more than 40 patents already granted around the technology.

Proactive: James, Recce Pharmaceuticals recently raised funds, and there is also a share purchase plan underway. How will those funds be deployed across clinical, regulatory and licensing activities?

James Graham: The key phrase there is licensing activities.

We announced a term sheet with a leading Middle Eastern pharmaceutical company. The prevalence of diabetes in the Middle East is more than 30%, at around 35%.

As mentioned, of those who have diabetes, around 60% will develop a diabetic foot ulcer.

The term sheet covers approximately 11 countries and a 10-year licence. It is targeting net royalties to Recce Pharmaceuticals of between 30% and 36%, based on a selling price of US$1,500.

It represents a good market opportunity and significant market coverage. We look forward to progressing it into a definitive agreement, which we are actively working on at this time.

The funds are being used to support that process.

Proactive: There is clearly a lot to look forward to. What will be happening over the next few months?

James Graham: Clinical data will be the primary focus. We have two Phase 3 studies underway.

As mentioned, one is in Indonesia because of the prevalence within the patient population and the potential for data harmonisation across ASEAN and the Middle East.

We expect that product to be approved at the end of this year, with sales targeted for next year and beyond.

In Australia, the same study is running across multiple Australian teaching hospitals. That study is focused on the US Food and Drug Administration. It is being conducted to FDA standards and under an FDA-aligned protocol.

We would expect to submit that program for approval at the end of next year.

These are two market strategies, both focused on the unmet medical need associated with diabetic foot ulcer infections.

Proactive: There is plenty to look forward to, and we will catch up again as it all unfolds. Thanks for your time today.

James Graham: Thanks, Jonathan.

J.B. Hunt Transport Services delivered strong Q2 2026 results, with accelerating intermodal volume and profit growth outpacing revenue gains. The IM segment EBIT soared 58% on 10% volume growth, demonstrating operating leverage and network efficiency before a major pricing reset. Dedicated remains a stable earnings base with 96% retention, while ICS and TL segments show early signs of recovery but face margin pressure from higher costs.

When Space Exploration Technologies Corp. (SPCX 3.07%) went public last month, it didn't just mint a new trillion-dollar stock; it sucked the air out of the room for every other space industry stock on the market. Investors sold shares of nearly every other space company to free up cash for the shiny new giant, and the whole group tumbled in what I like to call the "SpaceX Effect."

Rising interest rates helped compound the sell-off, hitting these long-duration growth stories especially hard. To me, that kind of indiscriminate, sentiment-driven sell-off is exactly when opportunity shows up.

Here are two names I'd buy the dip on without hesitation.

Image source: Getty Images.

Rocket Lab: a real business on sale Rocket Lab (RKLB 11.62%) fell sharply during the pullback, and I think that's a gift. Unlike most of the sector, this is a genuine operating business with two growth engines, launching rockets while also building satellites and components for other customers.  The company reported revenue that grew more than 60% year over year in its most recent quarter, backed by a multibillion-dollar backlog. The catalysts ahead are meaty, too: its larger Neutron rocket is targeted to make its debut later this year, it just qualified to compete for the Space Force's $5.6 billion national-security launch program, and it's buying its way toward full vertical integration with a deal for an operating satellite constellation. The dip lowered the price on a company that is arguably furthest along the path to standing on its own.

Today's Change

(

-11.62

%) $

-8.86

Current Price

$

67.35

AST SpaceMobile: the moonshot with catalysts AST SpaceMobile (ASTS 17.03%) is the more speculative of my two picks, but the sell-off makes its risk-reward more attractive. The company is building a network to beam broadband from satellites directly to ordinary smartphones, and it just cleared its biggest regulatory hurdle by winning U.S. commercial authorization. It's launching satellites on a real cadence, sits on billions in cash, and has locked in more than a billion dollars of contracted commitments from wireless carriers. The stock got swept lower with everything else, even as its actual progress accelerated -- the kind of disconnect I like to buy into.

Today's Change

(

-17.03

%) $

-11.30

Current Price

$

55.02

The risks investors need to accept with these 2 stocks I won't pretend these are safe. Rocket Lab still has to fly Neutron on schedule, and new rockets are notorious for development delays. AST isn't consistently profitable and is spending heavily to build a network that must work at scale. Both are volatile and tied to a boom-and-bust sector. "Without hesitation" reflects my conviction in the long-term stories, not a belief that the ride will be smooth.

SpaceX knocked down good companies across the board, and that's precisely the dislocation patient investors can exploit. I'd buy Rocket Lab as the sturdier, revenue-generating anchor and AST SpaceMobile as the higher-upside swing, sizing each as a speculative position. The market sold the sector on rotation, not on broken fundamentals, and that gap is the opportunity.

Retail enthusiasm for Strategy (NASDAQ:MSTR | MSTR Price Prediction), still commonly known as MicroStrategy, has curdled in weeks. Shares closed at $94.03 on Thursday, down about 3.5% on the day, off over 23% in the past month, and down more than 79% over the past year. Reddit sentiment mirrors the slide: the Reddit sentiment score collapsed from 94 (very bullish) on June 30 to a range of 18 to 28 (bearish to very bearish) this week.

On July 5, Strategy disclosed the sale of 3,588 bitcoin worth roughly $225 million to fund preferred stock dividends, a move retail investors read as the first material crack in the leveraged bitcoin treasury model. Bitcoin itself is near $62,900, down 47% year over year, and MicroStrategy’s Q1 2026 EPS of −$38.25, missing expectations, driven by a $14.46 billion unrealized loss on digital assets.

Reddit’s Mood Snapped on the Bitcoin Sale Discussion volume peaked on June 30 with 4,247 upvotes and 322 comments, then flipped bearish as the liquidation post from user Kazgarth_ pulled in 2,923 upvotes and 340 comments on r/wallstreetbets. r/investing piled on with a fundamentals critique, arguing that Strategy now “trades below the value of its btc holdings and the premium that made the model work has flipped to a discount.”

The bear case retail investors are coalescing around:

Strategy is selling bitcoin to cover $750 million to $800 million in annual preferred dividend obligations, with $229.53 million paid in Q1 2026 alone. The firm carries $8.17 billion in long-term debt and raised $11.68 billion year to date in fresh equity, diluting common holders. Bitcoin’s average cost basis of $75,699 now stands well above spot, turning debt refinancing expensive. The tone has shifted from euphoria to gallows humor. One July 16 post titled “Volatility is Vitality” chronicled a friend whose $540,000 position, valued at its November 2024 peak, evaporated after rolling calls forward.

MicroStrategy vs. the Spot ETF Alternative Polymarket traders are pricing the near term tightly: the $105 upside strike carries just 21% odds this week. Spot bitcoin ETFs from BlackRock and Fidelity offer direct exposure without the preferred dividend drag, an alternative that did not exist during Strategy’s 2024 bull run. With BTC weakness persisting, watch the next preferred stock issuance and any further bitcoin sales as the tell on whether management’s “intelligent leverage” thesis still holds.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and MicroStrategy didn't make the cut. Grab the names FREE today.

Contact [email protected] for any questions or corrections.

The EUR/USD forecast remains biased to the downside as geopolitical tensions in the Middle East continue to underpin demand for both crude oil and the US dollar. Although this week’s softer US inflation readings briefly encouraged hopes that the Fed may not have to tightening after all, the renewed rise in oil prices has complicated that narrative and prompted investors to reassess the outlook. As such, they have found it difficult to justify shorting higher-yielding currencies or buying low or zero yielding assets. This narrative is unlikely to change much until there is genuine breakthrough in the tension between the US and Iran.

Dollar remains on front-foot as oil risk clouds inflation outlook This week we had some weak inflation numbers from the US, and that caused only temporary weakness in US dollar. Both consumer and producer inflation surprised on the downside, reinforcing the view that underlying price pressures are gradually easing. Under normal circumstances, that would have weighed on the greenback more meaningfully. Instead, markets have been reluctant to fully embrace that view as crude oil prices continue to climb amid escalating tensions between the United States and Iran.

Higher energy prices raise the risk that inflation proves more persistent later in the year, potentially delaying any shift towards easier monetary policy. While investors still expect inflation to moderate over the medium term, the near-term backdrop has become considerably less favourable for dollar bears. I continue to believe that a stronger dollar is the more likely outcome in so far as the near-term is concerned, assuming geopolitical risks do not fade abruptly, and energy prices retreat. That makes the near-term EUR/USD forecast slightly bearish.

Fed policymakers remain reluctant to soften their stance Despite encouraging inflation data, Federal Reserve officials have made little effort to signal an imminent policy pivot. Chair Kevin Warsh and Governor Chris Waller both reiterated that one or two favourable inflation reports are insufficient evidence that price stability has been restored. With crude oil prices moving sharply higher, policymakers will be wary of declaring victory too early. Energy costs rising means the Fed is unlikely to abandon its cautious approach until it sees sustained evidence that inflation is returning towards target. Markets continue to price in one rate increase before year-end. Should expectations shift towards a more aggressive policy path, the dollar could extend its recent gains while risk assets may struggle to maintain their resilience.

ECB meeting could provide the next catalyst For the euro, attention now turns to next week’s European Central Bank meeting. Although policymakers are widely expected to leave interest rates unchanged, rising energy prices have injected a degree of uncertainty into the outlook. The ECB faces an uncomfortable balancing act. On one hand, inflation has continued to moderate across much of the eurozone. On the other, higher oil prices threaten to revive inflationary pressures while simultaneously weighing on economic growth, raising the spectre of stagflation.

Some policymakers may therefore argue for maintaining a hawkish bias to preserve the ECB’s inflation-fighting credibility. Investors will be paying close attention to President Lagarde’s guidance for clues on whether policymakers are becoming more concerned about renewed energy-driven inflation.

Beyond the ECB, next week’s flash PMI surveys will offer a timely snapshot of business activity across the major economies and could shape expectations for both European growth and the direction of the euro over the coming weeks.

Technical EUR/USD forecast: Key levels to watch The EUR/USD managed to find support from the support trend of its flag pattern near the 1.1380 area earlier this week. That led to a bounce to test resistance and the bearish trend line around 1.1475/80 zone. From there, we have since seen renewed weakness. As a result, the EUR/USD continues to remain inside its bear flag pattern, and below the bearish trend line. While momentum is clearly lacking, the overall technical bias is one that leans slightly on the bearish side of things. The onus is on the bulls to show up and change that trend. Until that happens, the near-term EUR/USD forecast from a technical analysis point of view remains to the downside.

Source: TradingView.com Should the EUR/USD break below the bear flag, then the next target would be the 1.1300 handle. Conversely, a break above the short-term bearish trend could expose the 1.1500 handle for a retest with the next resistance not seen until 1.1575 – 1.1600 area.

-- Written by Fawad Razaqzada, Market Analyst

Follow Fawad on Twitter @Trader_F_R

Bonk (BONK) extends its losses, trading below $0.0000034 on Friday, losing over 16% so far this week. The ongoing correction was fueled by on-chain data indicating that the hacker behind the recent exploit transferred a portion of the stolen tokens to Binance. The move has heightened concerns about increased selling pressure, while the hacker still holds roughly $10.85 million in BONK, leaving the meme coin vulnerable to further declines.

Stolen BONK transfers to Binance weigh on price outlookLookonchain data shows that the hacker who had stolen $21.2 million the previous week deposited $4.11 million worth of BONK on Binance on Friday. 

As explained in the previous report, if the attackers move the stolen BONK tokens to exchanges to liquidate their holdings, it would bring renewed selling pressure, causing BONK to slip more. Since the hack on July 6, Bonk price has corrected more than 26% as of Friday.

Moreover, traders should still be cautious, as the hacker still holds roughly $10.85 million in BONK, raising the risk of further downside.

Bonk Price Forecast: How low can BONK go?Bonk price faced rejection from the 50-day Exponential Moving Average (EMA) around $0.0000045 on July 6 and corrected more than 26% so far this Friday, trading at $0.0000032.

If the meme coin continues its correction, it could extend the losses toward the key psychological support at $0.0000030.

Momentum indicators show bears in control. The Relative Strength Index (RSI) on the daily chart reads 30, near the oversold level, indicating strong bearish momentum. Meanwhile, the Moving Average Convergence Divergence (MACD) continues to signal a bearish crossover, with rising red histogram bars, which support the negative outlook.

BONK/USDT daily chartIf BONK recovers, it could extend the advance toward the 50-day EMA at $0.0000045.

Football and crypto have been circling each other for years through sponsorships, fan tokens, and NFT collectibles. Zoomex has taken a more direct route by connecting the two markets together, letting users trade on match outcomes with the same tools they already use to trade crypto. The result is Zoomex Predict World, a prediction market built for the 2026 World Cup and designed to feel less like a betting slip and more like a live order book.

Source: Zoomex

What Predict World Actually Is Zoomex Predict World is the flagship sports application of Zoomex’s new Prediction Market product, an event-based trading system that lets users take a position on an outcome, whether that’s a football result, a crypto price level, or another real-world event, and trade that position as conditions change. Inside the World Cup zone specifically, users pick match events, review the available outcomes alongside their current market prices or implied probabilities, and enter a position using crypto through their Zoomex account.

The part that separates this from a traditional prediction pool is what happens after the position is opened. A correct call at kickoff doesn’t need to be held blindly until the final whistle. As the match develops, goals go in, cards get shown, injuries happen, substitutions shift momentum, users can sell their existing shares, add to a position, trim it, or flip to the opposite outcome entirely. Prediction shares are priced continuously, so match events translate into price movement the same way news moves a crypto pair. That turns a pre-match guess into something closer to an in-play trading session, run through the same interface Zoomex traders already know.

The World Cup Campaign Zoomex paired the product launch with a dedicated World Cup Football Carnival campaign, running as a prediction market from June 11 through July 19, 2026 (UTC), with qualifying points valid through July 26 and rewards distributed between July 26 and July 31, 2026. Entry is free, and participants can forecast match outcomes, finalists, and the eventual champion directly from the Zoomex app.

Source: Zoomex

On top of the predictions themselves, Zoomex layered in a task-based rewards system. Users unlock Lucky Spin chances by:

Reaching cumulative valid prediction amount thresholds Completing a set number of valid predictions each day Racking up correct predictions over time Inviting friends to join the World Cup predictions Those spins feed into a prize pool that includes World Cup final and semi-final live match tickets, World Cup-themed gift boxes, airdrop rewards, margin deduction coupons, copy trading insurance funds, and futures trial funds, all on top of a reported $1,000,000 total prize pool for the campaign. Full mechanics, timelines, and eligibility details are published on the Zoomex campaign page and official channels, so it’s worth checking there before jumping in.

Beyond Sports: Politics, Macro, and Global Events The World Cup zone is just one filter inside Predict World. Browse the full markets view and the category tabs make the range clear: alongside sports, there’s Trump, Fed Interest Rate, Macro Indicators, and Inflation, each holding a live board of yes/no markets with real-time pricing and trading volume attached.

The mix on any given day can span geopolitics and monetary policy in the same scroll: a market on whether María Corina Machado enters Venezuela by a set date, another tracking the odds of a Russia nuclear test by specific 2026 deadlines, and a running board on Fed rate cuts broken out by meeting date, each priced individually with its own Yes/No spread. Macro releases get the same treatment, with a market on the June US annual inflation print offering separate outcome bands (such as at or below 3.6% versus exactly 3.7%) that traders can position on ahead of the data. Even political process questions show up, like a market on whether Trump renames ICE to NICE by year-end, split into short-term and longer-dated windows. Some of these single markets carry trading volumes in the tens of millions, on par with what a mid-sized crypto pair might see in a day.

That range is the point. A trader who has a read on Fed policy doesn’t need to leave Zoomex to act on it, and someone tracking inflation data or a geopolitical headline can turn that view into a position with the same mechanics used for the World Cup markets described above: enter early, adjust as new information lands, exit whenever the price no longer matches their view.

Why It’s Built for Crypto Traders Specifically Most prediction markets ask users to think like sports bettors. Zoomex Predict World asks them to think like traders, because that’s exactly the audience it’s built for. Match outcomes become event-based assets. Market prices reflect the crowd’s live expectations, not a fixed pre-match line. Someone who already understands how to manage a position on Zoomex, when to add exposure, when to cut it, when the market has clearly turned, can apply the same instincts to a football match as they would to a volatile altcoin.

That’s the real pitch behind Predict World: it doesn’t ask crypto users to learn a new mental model. It hands them a World Cup-shaped version of the one they already use every day on Zoomex.

Getting Started Joining the campaign takes a few steps:

Open or log into your Zoomex account Head to the Predict World zone Browse upcoming match events and review current outcome pricing Enter a position with crypto, then manage it as the match plays out Complete daily and cumulative tasks to earn Lucky Spin chances toward the reward pool With the World Cup entering its most unpredictable stretch, the window to build up valid predictions and Lucky Spin entries is narrowing. Fans who want to combine tournament excitement with an actual trading edge can head to Zoomex Predict World now and put their read on the tournament to the test.

About Zoomex Founded in 2021, Zoomex is a global cryptocurrency trading platform focused on derivatives trading. The platform serves over 3 million users across 35+ countries and regions, offering access to 590+ trading pairs.  Built around easy to use, transparency, fairness, and speed, Zoomex provides a clear and efficient trading experience for users worldwide. 

Through its high-performance matching engine, clear asset and order displays, and transparent fee and rule mechanisms, Zoomex helps users better understand their account status, order execution, trading costs, and results. Zoomex maintains registrations, licenses, and regulatory statuses across multiple jurisdictions, including the U.S. MSB, Canada MSB, U.S. NFA, and Australia AUSTRAC, and has completed security audits conducted by blockchain security firm Hacken. The platform also continues to strengthen its trust framework through Proof of Reserves, Security & Transparency, Compliance Information, and Fees / Rules Transparency initiatives.  

Beyond trading, Zoomex builds a refined brand experience through elite sports partnerships, including the TGR Haas F1 Team, World Cup-winning goalkeeper Emiliano Martínez, and world-class tennis events such as Wimbledon. The values of speed, precision, discipline, fair play, and rule-based execution are closely aligned with Zoomex’s approach to derivatives trading.  

At Zoomex: Easy to Use. Transparent balance. Fair access to your earnings.

17.7.2026 13:48, BAAERBAG

Analytik Ben Maher ze společnosti Keefe Bruyette & Woods přistoupil ke zvýšení cílové ceny pro akcie Erste Group Bank na 124 EUR (3 124,8 Kč) z předchozích 117 EUR (2 948,4 Kč) při stálém doporučení na stupni „outperform“.

Akcie Erste Akcie Erste Group Bank (BAAERBAG) dnes na pražské burze klesají o 0,76 % na 2 730 Kč, na RM-SYSTÉMu pak rostou o 0,59 % na 2 748 Kč.

Zdroj: Bloomberg

Michal Šnobl
Fio banka, a.s.
Prohlášení